Jiayi Li
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Jiayi Li has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
- Aobing Cheng
Department of Anesthesiology, Guangzhou First People’s Hospital, School of Medicine, South China University of Technology, Guangzhou, Guangdong, China
2 shared publications - Jie Wang
Department of Biochemistry and Molecular Cell Biology, Shanghai Key Laboratory for Tumor Microenvironment and Inflammation, Shanghai Jiao Tong University School of Medicine, Shanghai, P.R. China
2 shared publications - Jingyi Wang
Department of Pharmacology and Chemical Biology, Shanghai Jiao Tong University School of Medicine, Shanghai, China
2 shared publications - Peng Zhang
Shanghai Jiao Tong University School of Medicine
2 shared publications - Hong-Zhuan Chen
Shuguang Lab of Future Health, Shanghai Frontiers Science Center of TCM Chemical Biology, Shuguang Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China
1 shared publication Kun Zhang
1 shared publication
Latest Publications
- Open Access
- 15 October 2026
- Published by Springer Nature in Research Square
Nitric oxide promotes Arc turnover via protein S-Nitrosylation
The activity-dependent turnover of the immediate-early gene product Arc contributes to synaptic plasticity by regulating AMPA receptor trafficking. Although Arc transcription and translation have been extensively studied, the mechanisms governing its rapid degradation remain incompletely understood. Here, using quantitative proteomics together with cultured neurons and an in vivo fear-conditioning paradigm, we identify neuronal nitric oxide synthase (nNOS)-derived nitric oxide (NO) as a regulator of activity-induced Arc turnover. Our findings indicate that NO promotes Arc degradation through S-Nitrosylation at Cys96 and Cys159. Mutation of these residues attenuated NO-dependent Arc turnover, prolonged Arc abundance, and enhanced AMPA receptor internalization. Thus, nNOS-derived NO may function as a temporal regulator that fine-tunes the duration of Arc-dependent synaptic signaling and helps maintain AMPA receptor homeostasis.
- 15 October 2026
- Published by Springer Nature in Research Square
Open AccessNitric oxide promotes Arc turnover via protein S-Nitrosylation
The activity-dependent turnover of the immediate-early gene product Arc contributes to synaptic plasticity by regulating AMPA receptor trafficking. Although Arc transcription and translation have been extensively studied, the mechanisms governing its rapid degradation remain incompletely understood. Here, using quantitative proteomics together with cultured neurons and an in vivo fear-conditioning paradigm, we identify neuronal nitric oxide synthase (nNOS)-derived nitric oxide (NO) as a regulator of activity-induced Arc turnover. Our findings indicate that NO promotes Arc degradation through S-Nitrosylation at Cys96 and Cys159. Mutation of these residues attenuated NO-dependent Arc turnover, prolonged Arc abundance, and enhanced AMPA receptor internalization. Thus, nNOS-derived NO may function as a temporal regulator that fine-tunes the duration of Arc-dependent synaptic signaling and helps maintain AMPA receptor homeostasis.
- Open Access
- 10 September 2024
- Published by Springer Nature in Communications Biology
- Vol. 7 (1) , 1-12
S-Nitrosylation of p39 promotes its degradation and contributes to synaptic dysfunction induced by β-amyloid peptide
Alzheimer’s disease (AD), characterized by cognitive decline, is increasingly recognized as a disorder marked by synaptic loss and dysfunction. Despite this understanding, the underlying pathophysiological mechanisms contributing to synaptic impairment remain largely unknown. In this study, we elucidate a previously undiscovered signaling pathway wherein the S-nitrosylation of the Cdk5 activator p39, a post-translational modification involving the addition of nitric oxide to protein cysteine residues, plays a crucial role in synaptic dysfunction associated with AD. Our investigation reveals heightened p39 S-nitrosylation in the brain of an amyloid precursor protein (APP)/presenilin 1 (PS1) transgenic mouse model of AD. Additionally, soluble amyloid-β oligomers (Aβ), implicated in synaptic loss in AD, induce p39 S-nitrosylation in cultured neurons. Notably, we uncover that p39 protein level is regulated by S-nitrosylation, with nitric oxide S-nitrosylating p39 at Cys265 and subsequently promoting its degradation. Furthermore, our study demonstrates that S-nitrosylation of p39 at Cys265 significantly contributes to amyloid-β (Aβ) peptide-induced dendrite retraction and spine loss. Collectively, our findings highlight S-nitrosylation of p39 as a novel aberrant redox protein modification involved in the pathogenesis of AD, suggesting its potential as a therapeutic target for the disease.
- 10 September 2024
- Published by Springer Nature in Communications Biology
- Vol. 7 (1) , 1-12
Open AccessS-Nitrosylation of p39 promotes its degradation and contributes to synaptic dysfunction induced by β-amyloid peptide
Alzheimer’s disease (AD), characterized by cognitive decline, is increasingly recognized as a disorder marked by synaptic loss and dysfunction. Despite this understanding, the underlying pathophysiological mechanisms contributing to synaptic impairment remain largely unknown. In this study, we elucidate a previously undiscovered signaling pathway wherein the S-nitrosylation of the Cdk5 activator p39, a post-translational modification involving the addition of nitric oxide to protein cysteine residues, plays a crucial role in synaptic dysfunction associated with AD. Our investigation reveals heightened p39 S-nitrosylation in the brain of an amyloid precursor protein (APP)/presenilin 1 (PS1) transgenic mouse model of AD. Additionally, soluble amyloid-β oligomers (Aβ), implicated in synaptic loss in AD, induce p39 S-nitrosylation in cultured neurons. Notably, we uncover that p39 protein level is regulated by S-nitrosylation, with nitric oxide S-nitrosylating p39 at Cys265 and subsequently promoting its degradation. Furthermore, our study demonstrates that S-nitrosylation of p39 at Cys265 significantly contributes to amyloid-β (Aβ) peptide-induced dendrite retraction and spine loss. Collectively, our findings highlight S-nitrosylation of p39 as a novel aberrant redox protein modification involved in the pathogenesis of AD, suggesting its potential as a therapeutic target for the disease.